As of June 2026, 1 paid clinical trial is recruiting for Lung disease in Denver, North Carolina. Lung disease trials cover asthma biologics, COPD inhalers, antifibrotic therapies, CFTR modulators, and new lung cancer treatments across the full spectrum of chronic and acute respiratory illness. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Denver has approximately 11 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Researchers run research studies in Denver, NC at 6 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Research Carolina Elite | Chronic Obstructive Pulmonary Disease, Narcolepsy, Narcolepsy Type 1 | 4 |
| Denver, North Carolina | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 2 |
| Alkermes Investigational Site | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Takeda Site 16 | Idiopathic Hypersomnia | 1 |
| Takeda Site 8 | Narcolepsy Type 2 | 1 |
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Denver from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 11 recruiting clinical trials in Denver, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Denver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Denver include Idiopathic Hypersomnia (5), Narcolepsy Type 1 (4), Narcolepsy Type 2 (4), Chronic Obstructive Pulmonary Disease (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Denver include Research Carolina Elite, Denver, North Carolina, Alkermes Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.